中药槐耳治疗消化系统恶性肿瘤的研究进展
陆亭谚、赵浩然、石松畅、李宗耀负责翻译和总结、撰稿；邵岩飞、陈敬贤、孙晶负责审校、提供意见。所有作者均阅读并同意最终稿。
收稿日期: 2025-05-25
网络出版日期: 2026-06-23
基金资助
国家自然科学基金(82473031);国家自然科学基金(82273344);大学生创新创业训练计划(19250101)
Progress of traditional Chinese herbal medicine Vanderbylia robiniophila in the treatment of malignant tumors of digestive system
Received date: 2025-05-25
Online published: 2026-06-23
消化系统恶性肿瘤发病率与死亡率较高，且近年来呈现年轻化趋势。尽管目前以手术切除为基础，联合新辅助放化疗、术后放化疗、靶向治疗和免疫治疗的综合治疗模式取得较大的突破，部分病人因耐药、分期晚或耐受差而预后不佳。槐耳作为一种传统中草药，已被用于消化系统恶性肿瘤的一线和辅助治疗，表现出一定的抑癌作用。近年来，多项体外实验证实了其部分抑癌作用机制，包括影响肿瘤细胞的干性，诱导肿瘤细胞死亡和调节肿瘤微环境等。本文总结了槐耳抗肿瘤分子作用机制的研究现状，强调槐耳治疗消化系统恶性肿瘤的潜力。此外，还综述了槐耳在不同消化系统恶性肿瘤中的治疗效果及相关分子机制，为其临床应用提供理论支持，对进一步研究槐耳的抑癌作用提出建议，为未来消化系统恶性肿瘤的综合治疗提出新方向。
陆亭谚 , 赵浩然 , 石松畅 , 李宗耀 综述 , 邵岩飞 , 陈敬贤 , 孙晶 审校 . 中药槐耳治疗消化系统恶性肿瘤的研究进展[J]. 外科理论与实践, 2026 , 31(02) : 175 -182 . DOI: 10.16139/j.1007-9610.2026.02.13
Malignant tumors of the digestive system are associated with high morbidity and mortality rates, and their incidence has been increasing among younger populations in recent years. Although current comprehensive treatment strategies, which are primarily based on surgical resection and integrated with neoadjuvant chemoradiotherapy, postoperative chemoradiation, targeted therapy, and immunotherapy, have achieved substantial progress, the prognosis for certain patients remains poor due to drug resistance, advanced disease stages, or poor treatment tolerance. Vanderbylia robiniophila, a traditional Chinese herbal medicine, has been utilized as both a first-line and adjunctive therapeutic agent for digestive system malignancies, and has demonstrated notable antitumor efficacy. In recent years, multiple in vitro studies have elucidated several underlying antitumor mechanisms, including modulation of tumor cell stemness, induction of tumor cell death, and regulation of the tumor microenvironment. This review summarized the current understanding of the molecular mechanisms through which Vanderbylia robiniophila exerts its antitumor effects, highlighting its considerable therapeutic potential in digestive system malignancies. In addition, it provided a comprehensive overview of the therapeutic efficacy and corresponding molecular mechanisms of Vanderbylia robiniophila across various digestive system cancers, thereby providing theoretical support for its clinical application. Furthermore, this review proposes future research directions to further elucidate the antitumor properties of Vanderbylia robiniophila, aiming to inform and inspire novel strategies for the comprehensive treatment of digestive system malignancies.
| [1] | 郑荣寿, 陈茹, 韩冰峰, 等. 2022年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2024, 46(3):221-231. |
| ZHENG R S, CHEN R, HAN B F, et al. Cancer incidence and mortality in China, 2022[J]. Chin J Oncol, 2024, 46(3):221-231. | |
| [2] | FARHANGNIA P, KHORRAMDELAZAD H, NICKHO H, et al. Current and future immunotherapeutic approaches in pancreatic cancer treatment[J]. J Hematol Oncol, 2024, 17(1):40. |
| [3] | LI H, YOU J, WEI Y, et al. Huaier improves the efficacy of anti-PD-L1 Ab in the treatment of hepatocellular carcinoma by regulating tumor immune microenvironment[J]. Phytomedicine, 2024,123:155189. |
| [4] | SUN Y, SUN T, WANG F, et al. A polysaccharide from the fungi of Huaier exhibits anti-tumor potential and immunomodulatory effects[J]. Carbohydr Polym, 2013, 92(1):577-582. |
| [5] | QI T, DONG Y, GAO Z, et al. Research progress on the anti-cancer molecular mechanisms of huaier[J]. Onco Targets Ther, 2020,13:12587-12599. |
| [6] | WANG Y X, YUAN H S. Research progress on chemical constituents and anti-tumor effects of Huai'er (Vanderbylia robiniophila)[J]. Mycosystema, 2021, 40(3):411-422. |
| [7] | WANG Y, LIU Y, HU Y. Optimization of polysaccharides extraction from trametes robiniophila and its antioxidant activities[J]. Carbohydr Polym, 2014,111:324-332. |
| [8] | 乔廷廷, 王禹, 苟红艳, 等. 中药槐耳治疗肺癌的机制研究进展[J]. 中华中医药学刊, 2026, 44(3):85-88. |
| QIAO T T, WANG Y, GOU H Y, et al. Research progress on the mechanism of traditional Chinese medicine-huaier in the treatment of lung cancer[J]. Chin Arch Tradit Chin Med, 2026, 44(3):85-88. | |
| [9] | 程芳, 崔政, 李强, 等. 槐耳通过ROS/PI3K/AKT/NF-κB通路诱导慢性髓系白血病K562细胞凋亡[J]. 中国医院药学杂志, 2025, 45(17):1947-1953. |
| CHENG F, CUI Z, LI Q, et al. Huaier induces apoptosis in chronic myeloid leukemia K562 cells through ROS/PI3K/AKT/NF-κB pathway[J]. Chin J Hosp Pharm, 2025, 45(17):1947-1953. | |
| [10] | 闫晓晓, 董永红, 梁蓉, 等. 槐耳颗粒联合SOX方案治疗进展期胃癌术后的疗效观察[J]. 山西中医药大学学报, 2020, 21(1):58-61,76. |
| YAN X X, DONG Y H, LIANG R, et al. The efficacy of Huai-er granule combined with SOX in treating post-operative gastric cancer patients[J]. J Shanxi Univ Chin Med, 2020, 21(1):58-61,76. | |
| [11] | BAJAJ J, DIAZ E, REYA T. Stem cells in cancer initiation and progression[J]. J Cell Biol, 2020, 219(1):e201911053. |
| [12] | SONG S, CHEN Q, LI Y, et al. Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma[J]. Gut, 2021, 70(12):2238-2248. |
| [13] | YANG L, SHI P, ZHAO G, et al. Targeting cancer stem cell pathways for cancer therapy[J]. Signal Transduct Target Ther, 2020, 5(1):8. |
| [14] | ZHENG J, LI C, WU X, et al. Huaier polysaccharides suppresses hepatocarcinoma MHCC97-H cell metastasis via inactivation of EMT and AEG-1 pathway[J]. Int J Biol Macromol, 2014,64:106-110. |
| [15] | SHI Y, YUAN L, XU J, et al. Huaier inhibits gastric cancer growth and hepatic metastasis by reducing syntenin expression and STAT3 phosphorylation[J]. J Oncol, 2022,2022:6065516. |
| [16] | FU Z, MA K, DONG B, et al. The synergistic antitumor effect of huaier combined with 5-Florouracil in human cholangiocarcinoma cells[J]. BMC Complement Altern Med, 2019, 19(1):203. |
| [17] | AIELLO N M, MADDIPATI R, NORGARD R J, et al. EMT subtype influences epithelial plasticity and mode of cell migration[J]. Dev Cell, 2018, 45(6):681-695.e4. |
| [18] | LIU J, XIAO Q, XIAO J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities[J]. Signal Transduct Target Ther, 2022, 7(1):3. |
| [19] | ZHANG T, WANG K, ZHANG J, et al. Huaier aqueous extract inhibits colorectal cancer stem cell growth partially via downregulation of the Wnt/β-catenin pathway[J]. Oncol Lett, 2013, 5(4):1171-1176. |
| [20] | DONG J, CHENG X D, ZHANG W D, et al. Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation[J]. J Med Chem, 2021, 64(13):8884-8915. |
| [21] | ZOU Y F, RONG Y M, CHEN Z X, et al. Effects of huaier extract on ameliorating colitis-associated colorectal tumorigenesis in mice[J]. Onco Targets Ther, 2020,13:8691-8704. |
| [22] | ZOU Y, XIONG H, XIONG H, et al. A polysaccharide from mushroom Huaier retards human hepatocellular carcinoma growth, angiogenesis, and metastasis in nude mice[J]. Tumour Biol, 2015, 36(4):2929-2936. |
| [23] | WANG X F, HU C, MO S W, et al. GPR30 activation promotes the progression of gastric cancer and plays a significant role in the Anti-GC effect of huaier[J]. J Oncol, 2022,2022:2410530. |
| [24] | CHENG X, ZHU C, CHEN Y, et al. Huaier relieves oxaliplatin-induced hepatotoxicity through activation of the PI3K/AKT/Nrf2 signaling pathway in C57BL/6 mice[J]. Heliyon, 2024, 10(17):e37010. |
| [25] | SANCHEZ CALLE A, KAWAMURA Y, YAMAMOTO Y, et al. Emerging roles of long non-coding RNA in cancer[J]. Cancer Sci, 2018, 109(7):2093-2100. |
| [26] | JI D, ZHENG W, HUANG P, et al. Huaier restrains cho-langiocarcinoma progression in vitro and in vivo through modulating lncRNA TP73-AS1 and inducing oxidative stress[J]. Onco Targets Ther, 2020,13:7819-7837. |
| [27] | VAZQUEZ A, BOND E E, LEVINE A J, et al. The gene-tics of the p53 pathway, apoptosis and cancer therapy[J]. Nat Rev Drug Discov, 2008, 7(12):979-987. |
| [28] | TOLEDO F, WAHL G M. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas[J]. Nat Rev Cancer, 2006, 6(12):909-923. |
| [29] | LOPEZ A, REYNA D E, GITEGO N, et al. Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer[J]. Nat Commun, 2022, 13(1):1199. |
| [30] | JI X, PAN C, LI X, et al. Trametes robiniophila may induce apoptosis and inhibit MMPs expression in the human gastric carcinoma cell line MKN-45[J]. Oncol Lett, 2017, 13(2):841-846. |
| [31] | LI S, SUN Y, SONG M, et al. NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pathological injury in mouse model of depression[J]. JCI Insight, 2021, 6(23):e146852. |
| [32] | ZHU Z, WANG X, ZHANG W, et al. Huaier suppresses pancreatic cancer progression via activating cell autophagy induced ferroptosis[J]. Front Oncol, 2022,12:960858. |
| [33] | ZHANG Z, SHEN C, ZHOU F. The natural medicinal fungus Huaier promotes the anti-hepatoma efficacy of sorafenib through the mammalian target of rapamycin-mediated autophagic cell death[J]. Med Oncol, 2022, 39(12):221. |
| [34] | BEBBER C M, MüLLER F, PRIETO CLEMENTE L, et al. Ferroptosis in cancer cell biology[J]. Cancers (Basel), 2020, 12(1):164. |
| [35] | XIE Y, LI J, KANG R, et al. Interplay between lipid metabolism and autophagy[J]. Front Cell Dev Biol, 2020,8:431. |
| [36] | JUNTTILA M R, DE SAUVAGE F J. Influence of tumour micro-environment heterogeneity on therapeutic response[J]. Nature, 2013, 501(7467):346-354. |
| [37] | LI C, WU X, ZHANG H, et al. A Huaier polysaccharide restrains hepatocellular carcinoma growth and metastasis by suppression angiogenesis[J]. Int J Biol Macromol, 2015,75:115-120. |
| [38] | HUANG S, WU B, LI D, et al. Knockdown of astrocyte elevated gene-1 inhibits tumor growth and modifies microRNAs expression profiles in human colorectal cancer cells[J]. Biochem Biophys Res Commun, 2014, 444(3):338-345. |
| [39] | SARKAR D. AEG-1/MTDH/LYRIC in liver cancer[J]. Adv Cancer Res, 2013,120:193-221. |
| [40] | CHU X, TIAN W, WANG Z, et al. Co-inhibition of TIGIT and PD-1/PD-L1 in cancer immunotherapy: mechanisms and clinical trials[J]. Mol Cancer, 2023, 22(1):93. |
| [41] | GAO S, LI X, DING X, et al. Huaier extract restrains the proliferative potential of endocrine-resistant breast cancer cells through increased ATM by suppressing miR-203[J]. Sci Rep, 2017, 7(1):7313. |
| [42] | TIAN Y, WU J, ZENG L, et al. Huaier polysaccharides suppress triple-negative breast cancer metastasis and epithelial-mesenchymal transition by inducing autophagic degradation of snail[J]. Cell Biosci, 2021, 11(1):170. |
| [43] | WANG J, WANG X, CHEN T, et al. Huaier extract inhi-bits breast cancer progression through a LncRNA-H19/MiR-675-5p pathway[J]. Cell Physiol Biochem, 2017, 44(2):581-593. |
| [44] | LUO K F, ZHOU L X, WU Z W, et al. Molecular mechanisms and therapeutic applications of huaier in breast cancer treatment[J]. Front Pharmacol, 2023,14:1269096. |
| [45] | LV F, LI X, WANG Y. An extraction from trametes robi-niophila murr. (Huaier) inhibits non-small cell lung cancer proliferation via targeting to epidermal growth factor receptor[J]. Bioengineered, 2022, 13(4):10931-10943. |
| [46] | CHEN Y, WU H, WANG X, et al. Huaier granule extract inhibit the proliferation and metastasis of lung cancer cells through down-regulation of MTDH, JAK2/STAT3 and MAPK signaling pathways[J]. Biomed Pharmacother, 2018,101:311-321. |
| [47] | JIN H, LIU C, LIU X, et al. Huaier suppresses cisplatin resistance in non-small cell lung cancer by inhibiting the JNK/JUN/IL-8 signaling pathway[J]. J Ethnopharmacol, 2024, 319(Pt 2):117270. |
| [48] | 曲平, 周芬, 谭玲芳, 等. 槐耳清膏联合常用化疗药物对人急性淋巴细胞白血病细胞Nalm-6和Sup-B15的影响[J]. 中国实验血液学杂志, 2020, 28(5):1451-1458. |
| QU P, ZHOU F, TAN L F, et al. Effect of huaier aqueous extract combined with routine chemo-therapeutic drugs on human acute lymphoblastic leukemia cells Nalm-6 and Sup-B15[J]. J Exp Hematol, 2020, 28(5):1451-1458. | |
| [49] | YUAN B, YIN C, YE X, et al. Differential effects of Huaier aqueous extract on human CD4+T lymphocytes from patients with primary immune thrombocytopenia[J]. Exp Hematol, 2021,101-102:58-67. |
/
| 〈 |
|
〉 |
